Thank you for browsing the Eisai website.
You are about to visit an external website.
(A new browsing window will be opened)
There is no argument that palliative care should be integrated into cancer care from diagnosis to death, but significant barriers, attitudinal, behavioural, economic, educational and legal, still limit this needed care for a large proportion of people with cancer…
But, the main question is… How can state-of-the-art cancer care with its focus on survival coexist with services that assist patients adapt to an uncertain future and support patients and families in planning and preparing for death? Does really the oncologists are well trained to explain properly the REAL situation to the patients? How about the emotional intelligence? What the patients think about this?
The project described in this briefing has translated theory into reality. Their efforts go directly to the questions of whether and how information skills have to be developed by clinicians and be integrated upstream in the continuum of cancer care.
Clinicians participating in this project discovered that cancer treatment and emotional intelligence, communication skills do go together. They become enthusiastic supporters of this model because they´ll see it improve the quality of care for their patients, thereby enhancing their own professional satisfaction as well.
The “Working Together, Learning Together“ Team (WTLT) is composed of 25 oncologists (from Andalucia), 4 psychologists and three breast cancer patients as advisory board.
The oncologist, president of “Actitud frente al Cancer“ Foundation and also breast cancer patient, coordinated all the workshop. A psychologist (Pilar Abad) served as consultant and leader of the training program. A distinguishing characteristic of the program is the extent the knowledge to other by sharing with other colleagues the experience.
Which were our goals? What we expected to achieve?
Approach to care to minimize the effects of the oncologist’s own attitudes toward death on the therapy, the oncologist should explore and confront personal death attitudes before explain the situation to the patients.
We´re primarily concerned with the emotional conflicts and defense mechanisms of the individual. Special issues of conflict and defense arise in the dying person, and this approach addresses them in the hope of resolving the psychic crisis to the fullest extent possible. Dying is the ultimate crisis of ego development, and as such is associated with intense infra-psychic turmoil.
People, and patients in particular, are unique in the way they perceive and cope with the anxiety, and stress also the way one patient feels is different from the way another patient does.
Undoubtedly, it is related to the personality, strength, faith, and hope that patients are feeling toward their sickness. Consequently, people and patients can learn how to manage the stress and anxiety, and our final objective is to help patients to reduce their level of anxiety and stress so that they can increase their quality of live.
There are several techniques, that can help an impact on the way people (and patients in particular) perceive their feelings and how they manage the stress. Offering a powerful tool to control their anxiety and stress related with the way they perceive their disease, will help patients to experience better quality of live.
This hhc activity consist in offering Mindfulness workshops for Patients diagnosed of Breast Cancer in the two main Hospitals in Murcia (Spain): Morales Messeguer and Hospital Virgen de la Arritxaca.
What is “Mindfulness” and what does it means?
There is a body of scientific evidence that support all the benefits of mindfulness specially controlling stress.
Mindfulness is a technique which can help people manage their mental health or simply gain more enjoyment from life and also mindfulness describes a way of approaching our thoughts and feelings so that we become more aware of them and react differently to them.
Mindfulness can help breast cancer patients to:
Mindfulness is a technique which can help people manage their mental health or simply gain more enjoyment from life. It involves making a special effort to give your full attention to what is happening in the present moment – to what’s happening in your body, your mind or your surroundings, for example – in a non-judgemental way. HERE and NOW
Mindfulness describes a way of approaching our thoughts and feelings so that we become more aware of them and react differently to them.
With this project, Eisai will contribuite to help patients with breast cancer, offering a very powerful tool to control their stress associated with their breast cancer processs.
Awareness and information campaign
Sport, especially as a team, favours the social integration of affected people and a better control of epileptic seizures.
The awareness and information campaign “In epilepsy we all play”, took place after the recent cases occurred in the course of football matches in Aragon and was driven by the Aragonese Football Federation and Eisai.
Campaña de concienciación e información
El deporte, especialmente en equipo, favorece la integración social de las personas afectadas y un mejor control de las crisis epilépticas.
La campaña de concienciación e información “En la epilepsia jugamos todos” se llevó a cabo después de los recientes casos ocurridos en el transcurso de los partidos de fútbol celebrados en Aragón gracias a la Federación Aragonesa de Fútbol y Eisai.
Eisai lanza la web ‘aboutmemoryproblems.com’ diseñada para ayudar a las personas a reconocer los primeros signos de la enfermedad de Alzheimer y proporcionar orientación sobre la búsqueda de ayuda y asesoramiento para aquellas personas preocupadas por alguien cercano.
Eisai firma una declaración con la Organización Mundial de la Salud (OMS) para suministrar gratuitamente un fármaco para la filariasis linfática primaria.
Lanzamiento de Zebinix® (acetato de eslicabazepina) en Suecia para el tratamiento adyuvante de las crisis de inicio parcial en adultos.
Eisai presenta las solicitudes regulatorias para el agente antitumoral en investigación mesilato de eribulina (E7389) en Japón, Estados Unidos y Europa.
Lanzamiento del agente antitumoral Halaven® (mesilato de eribulina) en Estados Unidos.
Epidays is an educational video game about epilepsy whose objective is that both patients and family members with epilepsy have at their disposal a practical guide to help them in the management of the disease serving as orientation, in everyday areas such as home or sport, as well as helping them to act in case of crisis.
In addition, this initiative has as a second objective, but no less important, to help alleviate the stigma and prejudice that fall on people suffering from the disease.
The project has the endorsement of the Spanish Society of Epilepsy (SEEP) and the Andalusian Society of Epilepsy (SADE), as well as of the associations of patients and family members throughout the Spanish territory: Association of Epilepsy of the Valencian Community (ALCE), the Galician Union of Epilepsy (UGADE), the Madrid Association of Epilepsy (AME) and the Spanish Association of People Affected by Severe Epilepsy (APEMSI).
Childhood is the time of life in when epilepsy appears more frequently and its characteristics change as the child grows, as a reflection of cerebral maturation, coexisting transient epilepsies with excellent prognosis, with severe and refractory to treatment
After the diagnosis, epilepsy bursts not only in the life of the child but also in the whole family, changing day-to-day habits and adopting other ones new and necessary, as security measures when facing any possible sudden and unpredictable crisis of the minor or teenager.
To inform, educate and raise awareness about epilepsy, both children and adolescents is essential and necessary and with this aim this video game was developed from Eisai.
Eisai launches ‘aboutmemoryproblems.com’ website designed to help people recognise the early signs of Alzheimer’s disease and provide guidance for seeking help and advice for those who are concerned about someone close to them.
Eisai signs a statement with the World Health Organization (WHO) to supply a primary lymphatic filariasis medicine free of charge.
>Zebinix® (eslicarbazepine acetate) launched in Sweden for the adjunctive treatment of partial-onset seizures in adults.
Eisai submits regulatory applications for investigational anticancer agent eribulin mesylate (E7389) in Japan, the United States and Europe.
Anticancer agent Halaven is launched in the United States.
Eisai subsidiary launched in Canada.